HDAC9 and cancer: Histone deacetylase (HDAC) inhibitors along with other drugs have shown a significant effect in targeting cancer cells [34]–[37]; and HDAC inhibitor valproic acid in combination with other drugs has been shown to be effective against advanced solid tumors in phase I trials [38].